Abstract
Establishing the cause and clinical severity of pulmonary hypertension is critical for management. The pathophysiology of dyspnea in PAH is complex and related to pulmonary vascular resistance. Although disease-specific treatments are now available, a cure for PAH remains elusive and trials of combination treatments to improve symptoms and outcomes are ongoing.
| Original language | English |
|---|---|
| Pages (from-to) | 76-84 |
| Number of pages | 9 |
| Journal | Current Opinion in Supportive and Palliative Care |
| Volume | 4 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Jun 2010 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Dyspnea
- Exercise tolerance
- Palliative care
- Pulmonary arteries
- Pulmonary hypertension
Fingerprint
Dive into the research topics of 'Management of dyspnea in advanced pulmonary arterial hypertension'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver